Chemical Structure : MHY5535
货号: PC-27669Not For Human Use, Lab Use Only.
MHY5535 is a potent PPARα antagonist, inhibits PPARα transcriptional activity with IC50 of 0.54 uM, effectively reduces ovarian cancer stem cells (CSCs) viability and self-renewal.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MHY5535 is a potent PPARα antagonist, inhibits PPARα transcriptional activity with IC50 of 0.54 uM, effectively reduces ovarian cancer stem cells (CSCs) viability and self-renewal.
MHY5535 inhibits ovarian CSC viability (IC50=6.22 uM) and stemness through PPARα antagonism.
MHY5535 impairs mitochondrial energy metabolism and fatty acid dependency in ovarian CSCs.
MHY5535 synergizes with standard chemotherapy to eradicate ovarian CSCs.
MHY5535 and doxorubicin combination therapy suppresses tumor growth in an ovarian CSC xenograft model.
| 分子量 | 595.71 | |
| 分子式 | C34H33N3O5S | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Min Joo Shin, et al. Biomed Pharmacother. 2026 Aug 12:203:119842.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright